Objectives To develop an evidence-based, consensus-driven service model for the identification, assessment and treatment of tic disorders in children and young people (CYP) in England, addressing the ...

Revenue growth in upper half of guidance range; double digit adjusted EPS growth year-over-year;21% quarterly bookings growth, driven by seven large deals Revenue of $5.4 billion increased ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...